Axsome Therapeutics (AXSM) is a leading biotechnology business based in the US. It opened the day at $73.88 after a previous close of $74.12. During the day the price has varied from a low of $73.8 to a high of $76.5. The latest price was $74.82 (25 minute delay). Axsome Therapeutics is listed on the NASDAQ and employs 393 staff. All prices are listed in US Dollars.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Open | $73.88 |
|---|---|
| High | $76.50 |
| Low | $73.80 |
| Close | $74.82 |
| Previous close | $74.12 |
| Change | $0.70 |
| Change % | 0.9444% |
| Volume | 473,164 |
| 52-week range | $20.63 - $82.85 |
|---|---|
| 50-day moving average | $69.61 |
| 200-day moving average | $63.57 |
| Wall St. target price | $111.92 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.78 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $74.82 from 2023-06-02
| 1 week (2023-05-30) | 7.73% |
|---|---|
| 1 month (2023-05-05) | 1.46% |
| 3 months (2023-03-06) | 12.82% |
| 6 months (2022-12-06) | -0.58% |
| 1 year (2022-06-06) | 188.10% |
|---|---|
| 2 years (2021-06-03) | 21.26% |
| 3 years (2020-06-05) | 77.38 |
| 5 years (2018-06-06) | 1,978.33% |
| Revenue TTM | $144.6 million |
|---|---|
| Gross profit TTM | $45.9 million |
| Return on assets TTM | -37.45% |
| Return on equity TTM | -250.92% |
| Profit margin | -109.75% |
| Book value | $2.57 |
| Market capitalisation | $3.2 billion |
TTM: trailing 12 months
We're not expecting Axsome Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Axsome Therapeutics's shares have ranged in value from as little as $20.63 up to $82.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axsome Therapeutics's is 1.9004. This would suggest that Axsome Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Axsome Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that is in Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial of for treating attention-deficit/hyperactivity disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
